Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) [Phase 3]
Phase 3 trial evaluating eltrombopag or placebo in combination with azacitidine for intermediate-1 to high-risk myelodysplastic syndromes wa…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
This update announces the completion of a clinical trial assessing neonatal hemorrhagic risk in thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide [Phase 1]
A Phase 1 dose-finding study of oral eltrombopag in sarcoma patients receiving Adriamycin and ifosfamide, focusing on thrombocytopenia; the …
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects [Phase 1]
GlaxoSmithKline completed a Phase 1 drug-drug interaction study evaluating eltrombopag with boceprevir and eltrombopag with telaprevir in he…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia [Phase 2]
Phase 2 trial comparing three immunosuppressive regimens for severe aplastic anemia; results of the study have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Observational Trial of a Therapeutic Platelet Transfusion Regimen
An observational trial evaluating a therapeutic platelet transfusion regimen for patients with acute myeloid leukemia and thrombocytopenia h…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Indirect Comparison Between Eltrombopag & Romiplostim
This completed clinical trial update presents an indirect comparison of eltrombopag and romiplostim for thrombocytopenia to assess relative …
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Meta-analysis - Eltrombopag
A meta-analysis update assessing the efficacy and safety of eltrombopag for thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [Phase 4]
Phase 4 trial evaluating Anti-D (Rho(D) immune globulin) for thrombocytopenia in adults with hepatitis C with or without HIV infection; the …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia [Phase 2]
A Phase 2 trial evaluating romiplostim for thrombocytopenia in hepatitis C-infected patients was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy [Phase 2]
A Phase 2 trial evaluating SB-497115 versus placebo in adults with cancer receiving chemotherapy has completed. The study targets chemothera…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating eltrombopag for thrombocytopenia in patients with relapsed multiple myeloma was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia [Phase 1]
A Phase I study of TXA127 in patients with low/intermediate-1 risk myelodysplastic syndromes and thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating cyclosporine for treating low blood counts caused by hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated unrelated hematopoietic stem cell transplantation for several genetic blood cell disorders, i…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
A pediatric clinical trial evaluated plasma response and outcomes in children with septic shock and thrombocytopenia-associated multiple org…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 2]
Eltrombopag was investigated in a Phase 2 study of thrombocytopenic patients with myelodysplastic syndromes or acute myeloid leukemia. The r…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Drug Etiology of Aplastic Anemia and Related Dyscrasias
NHLBI-sponsored clinical trial evaluating etiologies of aplastic anemia and related dyscrasias has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation [Phase 1]
Phase I study evaluating eltrombopag to boost platelet production after total body irradiation; the trial has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag [Phase 2]
Phase 2 trial evaluating safety and efficacy of eltrombopag in solid tumor patients with thrombocytopenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating eltrombopag for thrombocytopenia in chronic lymphocytic leukemia patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: rhTPO in Critical Patients With Thrombocytopenia [Phase 2, Phase 3]
An ongoing Phase 2/Phase 3 trial investigates recombinant human thrombopoietin (rhTPO) in critically ill patients with thrombocytopenia, inc…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) [Phase 4]
A Phase 4 clinical trial update assessing bone marrow morphology in adults treated with romiplostim for thrombocytopenia associated with idi…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects [Phase 1]
Phase 1 study assessing single-dose pharmacokinetics and pharmacodynamics of avatrombopag in healthy Japanese and White subjects.